comparemela.com
Home
Live Updates
FDA Denies Approval of Obeticholic Acid for Pre-Cirrhotic Fibrosis Due to NASH : comparemela.com
FDA Denies Approval of Obeticholic Acid for Pre-Cirrhotic Fibrosis Due to NASH
The FDA has issued a CRL to Intercept Pharmaceuticals regarding the NDA for obeticholic acid for pre-cirrhotic fibrosis due to NASH.
Related Keywords
Jerry Durso ,
Drug Administration ,
Intercept Pharmaceuticals ,
Gastrointestinal Drugs Advisory Committee ,
Complete Response Letter ,
New Drug Application ,
Drugs Advisory Committee ,
comparemela.com © 2020. All Rights Reserved.